Cargando...
2018 in review: FDA approvals of new molecular entities
The number of new drug approvals in 2018 hit a record high, as did the fraction approved for an orphan indication. Equally dramatic was a surge in the number of organizations participating in drug discovery combined with a second year of below-average mergers and acquisitions. 2018 was a remarkable...
Guardado en:
| Publicado en: | Drug Discov Today |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7580227/ https://ncbi.nlm.nih.gov/pubmed/31158510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2019.05.022 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|